As of Mar 27
| +2.24 / +0.74%|
The 21 analysts offering 12-month price forecasts for Actavis have a median target of 336.00, with a high estimate of 375.00 and a low estimate of 285.00. The median estimate represents a +10.69% increase from the last price of 303.56.
The current consensus among 26 polled investment analysts is to Buy stock in Actavis. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.